Safety and Efficacy of IV Infusion of Investigational Agent (TZP-101) in Patients With Diabetic Gastroparesis
Status:
Completed
Trial end date:
2008-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether TZP-101 is safe in people with diabetes.
Also to determine if TZP-101 is effective in increasing the gastric emptying rate in diabetic
patients.